These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 2786565
1. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs. Youngster SK, Nicklas WJ, Heikkila RE. J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565 [Abstract] [Full Text] [Related]
2. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. Youngster SK, Sonsalla PK, Sieber BA, Heikkila RE. J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564 [Abstract] [Full Text] [Related]
3. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse. Sonsalla PK, Youngster SK, Kindt MV, Heikkila RE. J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874 [Abstract] [Full Text] [Related]
4. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Fuller RW, Hemrick-Luecke SK. Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637 [Abstract] [Full Text] [Related]
5. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine. Kindt MV, Heikkila RE, Nicklas WJ. J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818 [Abstract] [Full Text] [Related]
6. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK. J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514 [Abstract] [Full Text] [Related]
9. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline. Ogunrombi MO, Malan SF, Terre'Blanche G, Castagnoli K, Castagnoli N, Bergh JJ, Petzer JP. Life Sci; 2007 Jul 19; 81(6):458-67. PubMed ID: 17655878 [Abstract] [Full Text] [Related]
10. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ. Nature; 2007 Jul 19; 319(6048):56-7. PubMed ID: 3484542 [Abstract] [Full Text] [Related]
11. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices. Ofori S, Heikkila RE, Nicklas WJ. J Pharmacol Exp Ther; 1989 Oct 19; 251(1):258-66. PubMed ID: 2571719 [Abstract] [Full Text] [Related]
12. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase. Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M. J Pharmacol Exp Ther; 1986 Aug 19; 238(2):648-52. PubMed ID: 3488394 [Abstract] [Full Text] [Related]
13. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies. Harik SI, Riachi NJ, Hritz MA, Berridge MS, Sayre LM. J Pharmacol Exp Ther; 1993 Aug 19; 266(2):790-5. PubMed ID: 8355208 [Abstract] [Full Text] [Related]
14. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Youngster SK, Sonsalla PK, Heikkila RE. J Neurochem; 1987 Mar 19; 48(3):929-34. PubMed ID: 3492590 [Abstract] [Full Text] [Related]
15. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat. Harik SI, Schmidley JW, Iacofano LA, Blue P, Arora PK, Sayre LM. J Pharmacol Exp Ther; 1987 May 19; 241(2):669-76. PubMed ID: 2437293 [Abstract] [Full Text] [Related]
16. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW, Robertson DW, Hemrick-Luecke SK. J Pharmacol Exp Ther; 1987 Feb 19; 240(2):415-20. PubMed ID: 3100775 [Abstract] [Full Text] [Related]
17. The role of MAO in MPTP toxicity--a review. Glover V, Gibb C, Sandler M. J Neural Transm Suppl; 1986 Feb 19; 20():65-76. PubMed ID: 3091762 [Abstract] [Full Text] [Related]
18. Age-dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): correlation with monoamine oxidase-B. Walsh SL, Wagner GC. Synapse; 1989 Feb 19; 3(4):308-14. PubMed ID: 2787063 [Abstract] [Full Text] [Related]
19. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Heikkila RE, Kindt MV, Sonsalla PK, Giovanni A, Youngster SK, McKeown KA, Singer TP. Proc Natl Acad Sci U S A; 1988 Aug 19; 85(16):6172-6. PubMed ID: 3137566 [Abstract] [Full Text] [Related]
20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM. J Neurochem; 1990 Sep 19; 55(3):870-7. PubMed ID: 2384758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]